Transaction #23019 · Form 4 · 0001682852-26-000187
Moderna, Inc. · Exercise / conversion · Common Stock
Moderna, Inc. · Transacted October 14, 2026 · Filed October 16, 2026
What does this filing report?
An SEC Form 4 filing for Moderna, Inc. records an exercise / conversion involving Common Stock on October 14, 2026. The reported quantity was 76,453. The filing date is October 16, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Moderna, Inc.
- Company CIK
- 0001682852
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 76,453
- Reported price
- 12.21
- Reference value
- 933,491.13
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 1,638,482
- Ownership description
- Not reported
- SEC acceptance time
- Oct 16, 2026, 4:09 PM EDT
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Hoge Stephen ↗
President
CIK 0001760669
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2026.
- F2
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $213.03 to $213.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- F3
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $214.05 to $214.37. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- F4
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $220.60 to $221.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- F5
- These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
- F6
- This option is fully vested and exercisable.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.